Robuta

https://www.cochrane.org/zh-hant/evidence/CD008585_beta2-adrenoceptor-agonists-primary-dysmenorrhoea Beta2-adrenoceptor agonists for primary dysmenorrhoea | Cochrane for primary agonists dysmenorrhoea cochrane https://pmc.ncbi.nlm.nih.gov/articles/PMC8982518/ Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea - PMC Dysmenorrhoea is the occurrence of painful menstrual cramps of uterine origin and is a very common gynaecological complaint with negative effect on a... primary and secondary https://collections.nlm.nih.gov/catalog/nlm:nlmuid-101161260-bk Clinical lecture: dysmenorrhoea from haematoma of the ovary -- double dermoid cyst of the ovary --... of the clinical lecture dysmenorrhoea https://pubmed.ncbi.nlm.nih.gov/8935744/ Curative treatment of primary (spasmodic) dysmenorrhoea To prove the efficacy of oral vitamin B1 administration for the treatment of primary dysmenorrhoea, a randomised, double-blind, placebo-controlled study was... curative treatment primary dysmenorrhoea https://pubmed.ncbi.nlm.nih.gov/20184568/ Acupuncture for primary dysmenorrhoea: a systematic review The review found promising evidence in the form of RCTs for the use of acupuncture in the treatment of primary dysmenorrhoea compared with pharmacological... for primary acupuncture dysmenorrhoea systematic review https://pubmed.ncbi.nlm.nih.gov/29675890/ The prevalence and potential determinants of dysmenorrhoea and other pelvic pain in women: a... Pelvic pain was common at age 38, especially dysmenorrhoea (46.2%), and no improvement was detected following childbirth. pelvic pain in women https://www.cochrane.org/de/evidence/CD008585_beta2-adrenoceptor-agonists-primary-dysmenorrhoea Beta2-adrenoceptor agonists for primary dysmenorrhoea | Cochrane for primary agonists dysmenorrhoea cochrane